A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/16 (2006.01) A61K 31/336 (2006.01) A61K 31/40 (2006.01) A61K 31/4353 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61K 31/5377 (2006.01) A61P 27/06 (2006.01)
Patent
CA 2680838
The object is to find a novel pharmacological activity of a compound capable of inhibiting an HDAC. The compound capable of inhibiting a histone deacetylase has an excellent ability of changing the cytomorphology of a trabeculara cell and/or an excellent ocular hypotensive activity, and is therefore useful as a prophylactic and/or therapeutic agent for a disease associated with aqueous humor circulation and/or ocular tension, particularly a prophylactic and/or therapeutic agent for glaucoma, ocular hypertension or the like.
L'objectif est de trouver une nouvelle activité pharmacologique d'un composé capable d'inhiber une histone désacétylase (HDAC). Le composé capable d'inhiber une histone désacétylase a une excellente aptitude à changer la cytomorphologie d'une cellule trabéculaire et/ou une activité hypotensive oculaire excellente, et est par conséquent utile comme agent prophylactique et/ou thérapeutique pour une maladie associée à une circulation d'humeur aqueuse et/ou une tension oculaire, en particulier un agent prophylactique et/ou thérapeutique pour un glaucome, une hypertension oculaire ou similaires.
Fujikawa Junko
Fujisawa Koushi
Kirihara Tomoko
Shimazaki Atsushi
Tajima Hisashi
Fetherstonhaugh & Co.
Santen Pharmaceutical Co. Ltd.
LandOfFree
Intraocular pressure-lowering agent comprising compound... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraocular pressure-lowering agent comprising compound..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure-lowering agent comprising compound... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1797488